Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor
Canada
2890238
Filed on 2013-11-01
2890238
Filed on 2013-11-01
Method of Reducing Adverse Effects in a Cancer Patient Undergoing Treatment with a MEK Inhibitor
Australia
2013337702
Filed on 2013-11-01
2013337702
Filed on 2013-11-01
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Sweden
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Italy
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
United Kingdom
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
France
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Spain
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Germany
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Switzerland
11706137.4
Filed on 2012-08-27
11706137.4
Filed on 2012-08-27
Calcineurin Inhibitor-antibody Conjugates For The Treatment Of Th17 Driven Inflammatory Diseases.
Patent Cooperation Treaty
PCT/GB2014/053804
Filed on 2014-12-19
PCT/GB2014/053804
Filed on 2014-12-19